pentobarbital will decrease the extent or impact of guanfacine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Solid or moderate CYP3A4 inducers significantly lessen guanfacine plasma concentrations and elimination 50 %-existence.pentobarbital will lower the level or impact of disopyramide by affecting hepat